Transparency and freedom of information releases

40 releases sorted by Updated (newest)

Of Type

Corporate report

From

Medicines and Healthcare products Regulatory Agency (MHRA)

  1. Human Medicines Regulations 2012 Advisory Bodies annual report 2018

    Annual report of the Human Medicines Regulations 2012 Advisory Bodies - the Commission on Human Medicines (CHM) and the British Pharmacopoeia Commission

  2. Medicines and Healthcare Products Regulatory Agency Annual Report and Accounts 2018 to 2019

    This document contains the MHRA annual report and accounts 2018 to 2019.

  3. Medicines and Healthcare products Regulatory Agency Business Plan 2019 to 20

    Second annual business plan to deliver the Medicines and Healthcare products Regulatory Agency’s Corporate Plan 2018-23

  4. MHRA: policy for handling conflicts of interest

    Information about how we handle potential conflicts of interest (COI) between MHRA, NIBSC and CPRD.

  5. Medicines and Healthcare Products Regulatory Agency Annual Report and Accounts 2017 to 2018

    This document contains the following information the MHRA annual report and accounts 2017 to 2018

  6. Review Panel Annual Report 2017

    Review Panel Annual Report 2017 - a panel that performs statutory and non-statutory reviews of proposals, decisions and provisional decisions taken by MHRA.

  7. Annual reports of the ABRHP and the HMAC

    Annual reports of the Advisory Board on the Registration of Homeopathic Products and the Herbal Medicines Advisory Committee.

  8. Human Medicines Regulations 2012 Advisory Bodies annual report 2017

    Annual report of the Human Medicines Regulations 2012 Advisory Bodies - the Commission on Human Medicines (CHM) and the British Pharmacopoeia Commission

  9. Medicines and Healthcare products Regulatory Agency Business Plan 2018 to 19

    First annual business plan to deliver the Medicines and Healthcare products Regulatory Agency’s Corporate Plan 2018-23

  10. MHRA Corporate Plan 2018 to 2023

    This plan outlines the Agency’s strategic direction over the next five years, including how we ensure a smooth EU exit under any scenario.

  11. Animal use in medicines and medical devices regulation

    MHRA has committed to being more transparent with the public about when, how and why we use animals.

  12. Review Panel Annual Report 2016

    Review Panel Annual Report 2016 - a panel that performs statutory and non-statutory reviews of proposals, decisions and provisional decisions taken by the MHRA.

  13. Advisory Board on the Registration of Homeopathic Products and Herbal Medicines Advisory Committee Annual Reports 2016

    Advisory Board on the Registration of Homeopathic Products and Herbal Medicines Advisory Committee Annual Reports 2016, along with a record of members' interests in the pharmaceutical industry.

  14. Human Medicines Regulations 2012 Advisory Bodies annual report 2016

    Annual report of the Human Medicines Regulations 2012 Advisory Bodies - the Commission on Human Medicines (CHM) and the British Pharmacopoeia Commission

  15. Medicines and Healthcare Products Regulatory Agency Annual Report and Accounts 2016 to 2017

    This document contains the following information: MHRA annual report and accounts 2016 to 2017

  16. Medicines and Healthcare products Regulatory Agency Business Plan 2017 to 18

    Fifth annual business plan to deliver the Medicines and Healthcare products Regulatory Agency’s Corporate Plan 2013-18 and its Corporate Plan Refresh 2016.

  17. Medicines and Healthcare products Regulatory Agency’s staff survey results 2016

    Survey of Medicines and Healthcare products Regulatory Agency staff taken in October 2016

  18. Medicines and Healthcare Products Regulatory Agency Annual Report and Accounts 2015 to 2016

    This document contains the following information: MHRA annual report and accounts 2015 to 2016.

  19. Human Medicines Regulations 2012 Advisory Bodies annual report 2015

    Annual report of the Human Medicines Regulations 2012 Advisory Bodies - the Commission on Human Medicines (CHM) and the British Pharmacopoeia Commission

  20. Reducing Regulatory Burden

    Report outlining the Medicines and Healthcare products Regulatory Agency’s (MHRA's) commitment to burden reduction activity.